• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜与开腹手术治疗肝门部胆管癌:短期和长期结局的回顾性队列研究。

Laparoscopic versus open surgery for hilar cholangiocarcinoma: a retrospective cohort study on short-term and long-term outcomes.

机构信息

Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, 250012, Shandong, China.

Department of Organ Transplantation, Qilu Hospital, Cheeloo College of Medicine, Shandong University, 107 Wenhuaxi Road, Jinan, 250012, Shandong, China.

出版信息

Surg Endosc. 2022 Jun;36(6):3721-3731. doi: 10.1007/s00464-021-08686-6. Epub 2021 Aug 16.

DOI:10.1007/s00464-021-08686-6
PMID:34398281
Abstract

BACKGROUND

Laparoscopic surgery (LS) for hilar cholangiocarcinoma (HCCa) remains under development, and its feasibility and safety remain controversial. This study therefore evaluated the outcomes of this technique and compared them to those of open surgery (OS).

METHODS

In total, 149 patients underwent surgical resection for HCCa at our center between February 2017 and September 2020. After screening and propensity score matching, 47 OS group patients and 20 LS group patients remained, and their baseline characteristics, pathologic findings, surgical outcomes, and long-term outcomes were compared.

RESULT

The baseline characteristics and pathologic findings were comparable between the two groups. The mean incision length was longer in the OS group than in the LS group (21.0 cm vs. 13.2 cm, P < 0.001). No significant differences were observed in the other surgical outcomes between the two groups. Regarding long-term outcomes, the overall survival rate and disease-free survival rate of the OS group were significantly higher than those of the LS group (P = 0.0057, P = 0.043). However, the two groups had significantly different follow-up times (19.2 months vs. 14.7 months, P = 0.041).

CONCLUSION

LS for HCCa is technically achievable, and our study revealed that it is equivalent to OS in terms of short-term outcomes but was poorer in terms of long-term outcomes.

摘要

背景

腹腔镜手术(LS)治疗肝门部胆管癌(HCCa)仍在发展中,其可行性和安全性仍存在争议。本研究因此评估了该技术的结果,并将其与开放手术(OS)的结果进行了比较。

方法

在我们中心,共有 149 例 HCCa 患者于 2017 年 2 月至 2020 年 9 月接受了手术切除。经过筛选和倾向评分匹配,保留了 47 例 OS 组患者和 20 例 LS 组患者,比较了他们的基线特征、病理发现、手术结果和长期结果。

结果

两组的基线特征和病理发现相似。OS 组的平均切口长度长于 LS 组(21.0cm 比 13.2cm,P<0.001)。两组其他手术结果无显著差异。关于长期结果,OS 组的总生存率和无病生存率明显高于 LS 组(P=0.0057,P=0.043)。然而,两组的随访时间有显著差异(19.2 个月比 14.7 个月,P=0.041)。

结论

LS 治疗 HCCa 在技术上是可行的,本研究表明,它在短期结果方面与 OS 相当,但在长期结果方面较差。

相似文献

1
Laparoscopic versus open surgery for hilar cholangiocarcinoma: a retrospective cohort study on short-term and long-term outcomes.腹腔镜与开腹手术治疗肝门部胆管癌:短期和长期结局的回顾性队列研究。
Surg Endosc. 2022 Jun;36(6):3721-3731. doi: 10.1007/s00464-021-08686-6. Epub 2021 Aug 16.
2
Survival analysis of laparoscopic surgery and open surgery for hilar cholangiocarcinoma: a retrospective cohort study.腹腔镜手术与开腹手术治疗肝门部胆管癌的生存分析:一项回顾性队列研究。
World J Surg Oncol. 2024 Feb 19;22(1):58. doi: 10.1186/s12957-024-03327-3.
3
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis.机器人辅助肝门部胆管癌根治术中胆肠重建效果的评估:单中心倾向评分匹配分析。
Sci Rep. 2024 Jun 27;14(1):14836. doi: 10.1038/s41598-024-65875-8.
4
Total laparoscopic versus open radical resection for hilar cholangiocarcinoma.全腹腔镜与开腹根治性切除术治疗肝门部胆管癌的比较。
Surg Endosc. 2020 Oct;34(10):4382-4387. doi: 10.1007/s00464-019-07211-0. Epub 2019 Oct 29.
5
Preliminary comparison of total laparoscopic and open radical resection for hepatic hilar cholangiocarcinoma a single-center cohort study.肝门部胆管癌全腹腔镜与开放根治性切除术的初步比较:一项单中心队列研究
Asian J Surg. 2023 Feb;46(2):856-862. doi: 10.1016/j.asjsur.2022.07.158. Epub 2022 Oct 4.
6
The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis.腹腔镜切除肝门周围胆管癌与开放手术的长期结果比较:一项真实世界的多中心分析。
Ann Surg Oncol. 2023 Mar;30(3):1366-1378. doi: 10.1245/s10434-022-12647-1. Epub 2022 Oct 22.
7
Laparoscopic versus open surgery for perihilar cholangiocarcinoma: a multicenter propensity score analysis of short- term outcomes.腹腔镜与开腹手术治疗肝门部胆管癌:短期结局的多中心倾向评分分析。
BMC Cancer. 2023 May 3;23(1):394. doi: 10.1186/s12885-023-10783-9.
8
Comparison of Efficacy and Safety Between Laparoscopic and Open Radical Resection for Hilar Cholangiocarcinoma-A Propensity Score-Matching Analysis.腹腔镜与开放根治性切除术治疗肝门部胆管癌的疗效与安全性比较——倾向评分匹配分析
Front Oncol. 2022 Sep 26;12:1004974. doi: 10.3389/fonc.2022.1004974. eCollection 2022.
9
[Robotic hilar cholangiocarcinoma radical resection compared with laparotomy in prognosis].机器人肝门部胆管癌根治性切除术与开腹手术预后的比较
Zhonghua Wai Ke Za Zhi. 2020 Mar 1;58(3):230-234. doi: 10.3760/cma.j.issn.0529-5815.2020.03.012.
10
Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching.腹腔镜肝切除术与开腹肝切除术治疗肝内胆管细胞癌:倾向评分匹配队列研究的 3 年结果。
Surg Oncol. 2020 Jun;33:63-69. doi: 10.1016/j.suronc.2020.01.001. Epub 2020 Jan 14.

引用本文的文献

1
Minimally invasive liver surgery for perihilar and intrahepatic cholangiocarcinoma: systematic review and meta-analysis of comparative studies.肝门部及肝内胆管癌的微创肝脏手术:比较研究的系统评价与荟萃分析
Surg Endosc. 2025 Sep 10. doi: 10.1007/s00464-025-11900-4.
2
Comparison of short- and long-term outcomes between robotic and laparoscopic operation in hilar cholangiocarcinoma patients: a case control study.肝门部胆管癌患者机器人手术与腹腔镜手术的短期和长期疗效比较:一项病例对照研究
Surg Endosc. 2025 Jun 13. doi: 10.1007/s00464-025-11742-0.
3
Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis.

本文引用的文献

1
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial.腹腔镜与开腹胰十二指肠切除术治疗胰腺或壶腹周围肿瘤:一项多中心、开放标签、随机对照试验。
Lancet Gastroenterol Hepatol. 2021 Jun;6(6):438-447. doi: 10.1016/S2468-1253(21)00054-6. Epub 2021 Apr 27.
2
Current status of laparoscopic radical hilar cholangiocarcinoma in Mainland China.中国大陆腹腔镜根治性肝门胆管癌的现状。
Biosci Trends. 2020 Jul 17;14(3):168-173. doi: 10.5582/bst.2020.03010. Epub 2020 May 9.
3
Perihilar cholangiocarcinoma: are we ready to step towards minimally invasiveness?
腹腔镜与开腹手术切除肝门部胆管癌的短期和长期预后:一项基于倾向评分的分析
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):207-221. doi: 10.21037/hbsn-23-680. Epub 2024 Aug 12.
4
Clinical comparative study of robot-assisted and traditional laparoscopic surgery in patients with cervical cancer: a retrospective cohort study.机器人辅助与传统腹腔镜手术治疗宫颈癌患者的临床对比研究:一项回顾性队列研究
BMC Surg. 2024 Dec 27;24(1):423. doi: 10.1186/s12893-024-02716-5.
5
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis.机器人辅助肝门部胆管癌根治术中胆肠重建效果的评估:单中心倾向评分匹配分析。
Sci Rep. 2024 Jun 27;14(1):14836. doi: 10.1038/s41598-024-65875-8.
6
Practice guidelines for managing extrahepatic biliary tract cancers.肝外胆管癌管理实践指南。
Ann Hepatobiliary Pancreat Surg. 2024 May 31;28(2):161-202. doi: 10.14701/ahbps.23-170. Epub 2024 Apr 29.
7
Survival analysis of laparoscopic surgery and open surgery for hilar cholangiocarcinoma: a retrospective cohort study.腹腔镜手术与开腹手术治疗肝门部胆管癌的生存分析:一项回顾性队列研究。
World J Surg Oncol. 2024 Feb 19;22(1):58. doi: 10.1186/s12957-024-03327-3.
8
Safety and feasibility of laparoscopic radical resection for bismuth types III and IV hilar cholangiocarcinoma: a single-center experience from China.腹腔镜根治性切除术治疗Bismuth Ⅲ型和Ⅳ型肝门部胆管癌的安全性和可行性:来自中国的单中心经验
Front Oncol. 2023 Dec 18;13:1280513. doi: 10.3389/fonc.2023.1280513. eCollection 2023.
9
Risk Factors for Negative Emotions in Patients Undergoing Radical Resection of Hilar Cholangiocarcinoma and Their Influence on Prognosis.肝门部胆管癌根治性切除患者负面情绪的危险因素及其对预后的影响。
Int J Gen Med. 2023 Dec 11;16:5841-5853. doi: 10.2147/IJGM.S440469. eCollection 2023.
10
Accurate resection of hilar cholangiocarcinoma using eOrganmap 3D reconstruction and full quantization technique.使用eOrganmap 3D重建和全量化技术精确切除肝门部胆管癌。
World J Gastrointest Surg. 2023 Aug 27;15(8):1693-1702. doi: 10.4240/wjgs.v15.i8.1693.
肝门部胆管癌:我们准备好迈向微创治疗了吗?
Updates Surg. 2020 Jun;72(2):423-433. doi: 10.1007/s13304-020-00752-3. Epub 2020 Mar 27.
4
The role of minimally invasive hepatectomy for hilar and intrahepatic cholangiocarcinoma: A systematic review of the literature.微创肝切除术治疗肝门部和肝内胆管细胞癌的作用:文献系统评价。
J Surg Oncol. 2020 Apr;121(5):863-872. doi: 10.1002/jso.25821. Epub 2020 Jan 4.
5
Laparoscopic resection for Bismuth type III and IV hilar cholangiocarcinoma: How to improve the radicality without direct palpation.腹腔镜下切除Ⅲ型和Ⅳ型肝门部胆管癌:如何在不直接触诊的情况下提高根治性。
J Surg Oncol. 2019 Dec;120(8):1379-1385. doi: 10.1002/jso.25739. Epub 2019 Nov 5.
6
Total laparoscopic versus open radical resection for hilar cholangiocarcinoma.全腹腔镜与开腹根治性切除术治疗肝门部胆管癌的比较。
Surg Endosc. 2020 Oct;34(10):4382-4387. doi: 10.1007/s00464-019-07211-0. Epub 2019 Oct 29.
7
Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma.新版美国癌症联合委员会癌症分期手册第 8 版评估肝门周围胆管癌。
J Gastrointest Surg. 2020 Jul;24(7):1612-1618. doi: 10.1007/s11605-019-04127-x. Epub 2019 Feb 12.
8
Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives.肝门部胆管癌的微创手术:现状与未来展望
ANZ J Surg. 2019 May;89(5):476-480. doi: 10.1111/ans.14765. Epub 2018 Aug 22.
9
A systematic surgical procedure: The '7+3' approach to laparoscopic right partial hepatectomy [deep segment (S) VI, S VII or S VIII] in 52 patients with liver tumors.一种系统性手术方法:52例肝肿瘤患者行腹腔镜右半肝切除术【肝段(S)VI、S VII或S VIII】的“7+3”入路
Oncol Lett. 2018 May;15(5):7846-7854. doi: 10.3892/ol.2018.8345. Epub 2018 Mar 23.
10
Cholangiocarcinoma - evolving concepts and therapeutic strategies.胆管癌——不断演变的概念与治疗策略
Nat Rev Clin Oncol. 2018 Feb;15(2):95-111. doi: 10.1038/nrclinonc.2017.157. Epub 2017 Oct 10.